Delivery Order SPE2DB22D1106-SPE2DB25FDYA4

Award Date 2/6/25
Potential Completion Date 2/7/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,083.02 and covers the supply of Sumatriptan 5 mg nasal sprays, with a period of performance through January 27, 2025. The contract was awarded on a firm-fixed price basis and does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,075,353 units of 20 mg Sumatriptan nasal sprays, with a ceiling value of $2,895.99. The contract is a firm fixed-price, delivery order type, with a period of performance through January 29, 2025. The contract was not set aside for any specific business category....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,147 units of 5 mg sumatriptan nasal sprays. The $7,803.05 contract has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,503.48 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 20mg Sumatriptan nasal sprays. The contract has a completion date of September 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,368.10 contract is for the supply of 4,566,566,086 units of Sumatriptan 20 mg nasal sprays, with a period of performance through November 29, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $2,057.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,576,146 units of Sumatriptan 20 mg nasal sprays, with a completion date of December 3, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order for $1,372.98 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,983,022 units of Sumatriptan 5 mg nasal sprays. The delivery order was issued under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for...
This is a $1,171.72 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 5 mg sumatriptan nasal sprays, a prescription medication used to treat migraine headaches. The contract has an ultimate completion date of September 9, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to support various...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Sumatriptan 20 mg nasal sprays. The contract has a firm fixed price of $3,090.72 and a completion date of July 31, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to supply a wide range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies, to...
This contract award, with ID SPE2DB24D1104|SPE2DB25FXVC9, is for the delivery of 4,566,582,835 units of 20 mg Sumatriptan nasal sprays. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price ceiling value of $5,388.35 and a completion date of December 3, 2024. This award is a delivery order, and no set-aside designation was used....
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDYA4
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 5 mg sumatriptan nasal sprays, with a ceiling value of $2,582.52 and a completion date of February 7, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/8/25, 9:45 AM